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A new rigid and conjugated ligand structure connecting phenan-
throline and poly(amino-carboxylate) binding sites provides d–f 
complexes which show high potential for use in dual (luminescence + 
magnetic resonance) imaging and for optimisation of d - f photo-
induced energy-transfer. 
 
Phosphorescent metal complexes oﬀ er major advantages over 
conventional fluorescent organic molecules as the basis of lumi-
nescent probes for cell imaging.
1–3
 The long luminescence lifetimes 
associated with triplet emission from complexes of e.g. Pt(II),
2a
 
Re(I),
2b
 Ir(III),
2c
 Ru(II),
2d
 and lanthanides,
2e
 allow simple rejection 
of short-lived background autofluorescence which might otherwise 
interfere. In addition, variations in luminescence lifetimes of such 
complexes (or ‘probes’) in different cellular regions, caused by the 
presence of different analytes such as O2, provide the basis of the 
recently-developed microsecond-scale lifetime mapping techniques 
phosphorescence lifetime imaging (PLIM)
2d,3
 and time-resolved 
emission microscopy (TREM).
2a,3b,c 
 
In addition, the use of highly paramagnetic complexes – often of 
Gd(III) – for magnetic resonance imaging (MRI) is now well 
established.
4
 Compared to luminescence-based imaging, MRI is 
quite complementary. Confocal microscopy offers excellent 
sensitivity and spatial resolution (particularly when two-photon 
excitation is used), but is limited in terms of tissue penetration; it is 
excellent for providing cellular-level detail. In contrast, MRI is 
capable of imaging whole bodies but with much lower spatial 
resolution. The combination of MRI with luminescence imaging 
methods using a single molecule is appealing as such a probe  
 
would combine the broad scope of MRI with the fine detail allowed 
by luminescence imaging.
5 
 
This possibility has stimulated interest in a range of hetero-
nuclear d–f complexes in which one or more phosphorescent d-block 
units is connected to one or more stable Gd(III) units. Notable recent 
examples have come from the groups of Faulkner
6
 and Parac-Vogt
7
 
amongst others.
5,8
 A common feature of these is that the Gd(III) unit 
is coordinated by a saturated poly-amino/ carboxylate ligand of the 
‘DTPA’ or ‘DOTA’ types as these provide the necessary high kinetic 
and thermodynamic stability in aqueous media. A disadvantage of 
these however is that the saturated skeletons can permit free rotation 
of the Gd(III) unit independently of the rest of the molecule, which 
limits relaxivity: high relaxivities arise from slow molecular 
tumbling in solution which gives long rotational correlation times, 
and many synthetic strategies have been employed specifically to 
rigidify Gd(III) complexes to increase their relaxivity.
4,5 
 
We report here a new ligand architecture (Fig. 1), which allows a 
strongly phosphorescent Ir(III) unit to be connected to a water-stable 
Gd(III) unit via a fully conjugated and rigid connector. 
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This results in both (i) long-lived luminescence which can be used in 
PLIM imaging under one-photon or two-photon excitation, and (ii) 
unusually long relaxivity from a single Gd(III) centre as a conse-
quence of the rigid design. The combination of Ir(III) and Gd(III) 
components for dual-imaging purposes has been very little explor-
ed
8c
 and this report is the first demonstration of PLIM using a 
complex that also has high relaxivity for MRI purposes. As an 
additional benefit, the same ligand architecture provides an eﬀ ective 
through-bond coupling pathway for eﬃcient Dexter Ir(III) - Eu(III) 
energy-transfer (EnT) in the isostructural Ir Eu complex. Dual-
luminescent d–f complexes are of interest for a range of applications 
from imaging
9
 to white-light emission
10
 and many of these applica-
tions hinge on the extent of d - f EnT which controls the balance of 
luminescence output from the two components.
11,12
 We prepared Ir 
Eu as an adjunct to Ir Gd to allow measurement of the q value 
around the Ln(III) centre, but its properties arising from the ligand 
structure are of significant interest in their own right.  
The complexes Ir Ln [where Ln = Gd(III) and Eu(III) respectively] 
are shown in Fig. 1. The Ir(III) unit is one of the well-known 
{Ir(F2phpy)2(NN)}
+
 units based on cyclometallating fluorinated 
phenyl-pyridine ligands.
13
 The Gd(III) coordination is provided by a 
heptadentate pyridine-2,6-bis(amino-diacetate) chelating unit,
14
 
connected to the {Ir(F2ppy)2(phen)}
+
 chromophore via an alkynyl 
linkage, providing the rigid, fully conjugated pathway containing no 
sp
3
-hybridised atoms. The key step is a Sonogashira coupling 
reaction between compounds A (the 4-bromopyridine with two 
pendant, protected, amino-diacetate arms) and 3-ethynyl-1,10-
phenanthroline (B). After assembling the ligand skeleton, coordina-
tion of the phen to an {Ir(F2ppy)2}
+
 unit, unmasking of the amino/ 
carboxylate binding site by removal of the esters, and finally 
incorporation of Ln(III), all used standard methods (see ESI†); the 
final products Ir Ln were purified by HPLC and characterised by 
mass spectrometry and elemental analysis.  
The UV/Vis absorption spectra of Ir A [the free tetracarboxylic 
acid complex with no Gd(III)] and Ir Ln show the usual intense 
absorptions in the visible region associated with ligand-centred p - 
p* transitions (see Fig. S14, ESI†). In addition the weak shoulder 
and long tail between 400 nm and 550 nm is ascribed to the Ir(III) -
phen MLCT transition.
13
 The luminescence of Ir A at 530 nm, and Ir 
Gd at 560 nm, are broad and featureless, indicative of 
3
MLCT 
luminescence (Fig. 2a): the red-shift in Ir Gd may be ascribed to the 
eﬀ ect of the Gd(III) ion whose positive charge stabilises the LUMO 
of the conjugated phen/alkyne/pyridyl ligand. Assignment of the 
luminescence as 
3
MLCT is supported by the substantial 
rigidichromism: at 77 K (MeOH/EtOH glass) the highest-energy 
feature in the luminescence spectrum of Ir Gd (which now shows a 
clear sequence of vibronic components, Fig. 2a) is blue-shifted from 
560 nm to 495 nm, giving an energy of 20 200 cm 
1
 for the Ir(III)-
based 
3
MLCT excited state. In aqueous solution at RT the Ir(III)-
based emission of Ir Gd (f = 4%) shows two decay components with 
lifetimes of t1: 1100 ns (56%) and t2: 450 ns (44%). The presence of 
two components is a common consequence of aggregation in 
solution,
12a,b
 possibly associated with the hydro-phobic {Ir(F2-
phpy)(phen)}
+
 units.  
The luminescence properties of Ir Eu are also of interest. The 
3
MLCT excited-state energy of the Ir(III)-component at 20 200 cm 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Luminescence spectra in MeOH/EtOH (1 : 4) of (a) Ir Gd, in fluid 
solution at RT (black) and as a frozen glass at 77 K (red); and (b) Ir Eu in 
fluid solution at RT (purple) and as a frozen glass at 77 K (green). lex = 400 
nm in all cases.  
 
is suﬃcient to allow sensitisation of the Eu(III) 5D0 state which lies at 
ca. 17 500 cm 
1
; at RT a gradient for EnT between donor (Ir) and 
acceptor (Eu) of ca. 2000 cm 
1
 is required.
15
 The luminescence 
spectrum of Ir Eu in solution (Fig. 2b) shows how partial Ir(III) - 
Eu(III) EnT has occurred, with the Ir(III)-based luminescence reduced 
in intensity by 22% compared to what was observed for Ir Gd, and 
five sharp luminescence lines at 580, 590, 615, 687 and 700 nm from 
the Eu(III) 
5
D0 - 
7
Dn transitions superimposed on the low-energy tail 
of the Ir(III)-based luminescence making it appear red (Fig. S13, 
ESI†). At 77 K the two emission components are more clearly 
separated because of the rigidochromic blue-shift of the Ir(III)-based 
emission component (Fig. 2b).  
The Ir(III) - Eu(III) EnT reduces the Ir(III)-based luminescence 
lifetime (compared to Ir Gd) to t1 = 780 and t2 = 116 ns (again, we 
see two components). If we make the reasonable assumption that 
Ir(III) - Eu(III) EnT provides the best additional deactivation pathway 
for Ir(III)-based luminescence in Ir Eu compared to what is possible 
in Ir Gd, then the shortest luminescence component of 116 ns in Ir 
Eu is associated with intramolecular quenching by Ir(III) - Eu(III) 
EnT. This gives from eqn (1) (where tu is the ‘unquenched’ lifetime 
from Ir Gd and tq is the ‘quenched’ lifetime from Ir Eu) an EnT rate 
kEnT of ca. 6 10
6
 s 
1
. Significantly this is an order of magnitude 
faster than we observed in our previous ‘rod-like’ water-soluble 
Ir(III)–Eu(III) dyad that was investigated for cell imaging, despite the 
greater Ir Eu separation. The markedly superior Ir(III) - Eu(III) EnT in 
Ir Eu can be ascribed to the fully conjugated pathway facilitating 
Dexter energy-transfer
12
 in this present system. All the 
photophysical results are summarised in Table S1 in ESI.† 
 
kEnT = 1/tq    1/tu (1) 
 
To assess the suitability of the complexes as probes for PLIM 
imaging, their cellular localization, emission properties and toxicity 
were evaluated in live MCF7 cells. Cells were incubated with Ir Ln 
at 25 mM, 50 mM and 100 mM for 4 and 24 hours in fully 
supplemented Roswell Park Memorial Institute (RPMI) media at 37 
1C. Steady-state confocal microscopy (typical images in Fig. 3A), 
shows that Ir Gd exhibits punctate cytoplasmic staining with some 
accumulation in the perinuclear region, the latter being most notable 
at high concentrations and long incubation times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Two-photon (lex = 780 nm) steady-state confocal imaging of Ir Ln 
complexes. Column (A), in descending order: DIC, emission and overlay 
images showing typical staining pattern of Ir Ln dyads in live MCF7 cells (Ir 
Gd, 50 mM, 4h). Column (B): cellular uptake comparison after 24 hour 
incubation with (in descending order): RPMI media only, Ir Eu (100 mM), Ir 
Gd (100 mM).  
 
Ir(III)-based emission was observed under both one-photon (458 nm) 
and two-photon (780 nm) excitation, consistent with the known 
modest two-photon absorption ability of Ir(III) complexes of this 
family.
9,16
 Optical sectioning (Fig. S21, ESI†) and co-staining with 
the commercial nuclear stain DAPI (Fig. S22, ESI†) confirm that Ir 
Gd was internalized into the cell cytoplasm, but did not cross the 
nuclear membrane.  
Interestingly, Ir Gd appeared to be internalized more rapidly than 
the isostructural Ir Eu complex. Fig. 3B shows steady-state confocal 
images after 24 hours incubation at 100 mM, recorded with the same 
laser power and detector gain. Emission from Ir Gd incubated cells 
is significantly brighter than that of Ir Eu, to the extent that the detail 
of the staining pattern cannot be clearly distinguished (due to the 
high detector gain). This diﬀ erence is not solely due to the 
inherently brighter Ir(III)-based emission in Ir Gd. The significant 
eﬀ ect Ir Gd has on the metabolic activity of MCF cells in 
comparison to Ir Eu suggest that considerably more Ir Gd is taken up 
by the cells (see Fig. S23, ESI†). The reason for this diﬀ erence in 
uptake between Ir Gd and Ir Eu is not obvious but the eﬀ ect is clear, 
with lower concentrations/shorter incubation times being typically 
preferred for Ir Gd. 
 
Lifetime mapping of the Ir(III)-based emission from both dyads 
was carried out using TP-PLIM (Fig. 4). In both cases, emission 
decays were best fit to a double exponential and only 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Two-photon PLIM imaging (lex = 780 nm, 12 ms imaging window) of 
Ir Eu (100 mM, 20 h) and Ir Gd (25 mM, 20 h) in live MCF7 cells. Top: 
intensity images, where all emitted photons are binned into one channel. 
Middle: t1 lifetime maps with rainbow legend set to 0–600 ns for both 
images, showing unifomity of cellular lifetime for each compound and the 
difference in Ir(III)-based emission lifetime between Ir Eu and Ir Gd. Bottom: 
emission decay traces and lifetime dsitributions of the Ir(III)-based emission 
from Ir Gd and Ir Eu in the cells.  
 
 
the major component (486%) t1 was used for plotting lifetime maps. 
The Ir(III)-based luminescence lifetimes are uniform across the cells 
for both dyads, with the lifetime values being comparable to those 
observed in aerated solution. Fig. 4 also highlights the clear 
diﬀ erence in Ir(III)-based luminescence lifetimes between Ir Gd and 
Ir Eu, brought about by energy transfer, by showing both lifetime 
maps set to the same parameters (rainbow chart = 0–600 ns). Ir Gd 
appears green (longer lifetime), whereas Ir Eu appears orange due a 
shorter lifetime. Example decay traces for each dyad were exported 
and overlaid for comparison (Fig. 4). 
 
From Ir Eu we found that the Eu(III)-based luminescence lifetimes 
were 0.42 ns in water and 1.14 ms in D2O, giving a value for q of 1.6 
0.5,
17
 comparable to what is observed with other Gd(III) complexes 
of heptadentate ligands used for MRI.
4,5
 Despite this, at 20 MHz and 
37 1C the relaxivity of Ir Gd is 11.9 mM 
1
 s 
1
, measured over a range 
of concentrations (see ESI†). This is considerably higher than that of 
typical mono-nuclear Gd(III) complexes (typically, 4–5 mM 
1
 s 
1
)
4,5
 
and must 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
be a consequence of the rigidity imposed on the complex by the 
conjugated linkage.  
Notably, this is comparable to relaxivity values observed in other 
d–f hybrids which contain three or four Gd(III) centres that are 
individually more flexible due to the saturated ligand skeletons.
5c
 
Thus the ligand design in Ir Gd is clearly effective at providing high 
relaxivity for a relatively low molecular weight complex without the 
need to incorporate several Gd(III) centres, or to conjugate the probe 
to a biomolecule to slow down its rotational correlation time. 
 
For imaging purposes with Ln(III)-containing complexes, kinetic 
stability is important due to the toxicity of free Ln(III) ions. The 
luminescence spectra of Ir Gd and Ir Eu showed no change after 
prolonged storage in aqueous solution: loss of the Ln(III) ion would 
result in each case in a blue shift of the Ir(III)-based emission 
maximum from 564 nm to 532 nm due to the generation of free Ir A 
(Fig. S15, ESI†). In addition, the kinetic stability of Ir Eu was 
measured by luminescence spectroscopy in the presence of 1 
equivalent of the competing ligand DOTA [the octadentate 
macrocyclic ligand system cyclen-1,4,7,10-tetraacetic acid, used as a 
Ln(III) receptor] at a concen-tration of 0.1 mM, in both water and in 
PBS buﬀ er (see Fig. S19 and S20 respectively, ESI†). If the Eu(III) 
ion were extracted from Ir Eu by the competing DOTA ligand, we 
would see a steady loss of sensitised Eu(III)-based luminescence as 
well as the blue-shift of the Ir(III)-based emission component. In the 
presence of DOTA, the Ir(III)-based emission showed no significant 
change in profile, and the sensitised Eu(III)-based luminescence 
remained almost intact (o5% decrease in intensity after 3 days), 
confirming the integrity of the complex even under these 
challenging conditions (Fig. S19, ESI†). When PBS buﬀ er was used 
as the medium, greater loss of Eu-based luminescence intensity was 
observed (Fig. S20, ESI†) presumably associated with the presence 
of phosphate.  
In conclusion, this ligand architecture oﬀ ers substantial scope for 
dual (luminescence + magnetic resonance) imaging using d–f 
complexes because of its rigidity; and for applications requiring d - f 
energy-transfer because of the conjugated pathway. Thus Ir Gd 
provides both the capacity for PLIM measurements as well as 
unusually high relaxivity for a mono-nuclear Gd(III) complex; and Ir 
Eu demonstrates unusually effective d - f Dexter energy-transfer. 
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